Language selection: PharmaLab Kongress - Switch to the German version of the website DE | PharmaLab Congress - English version of the websiteEN

Pest Control – from classic trap to digital control

20 November 2018

Objectives

This session will show you the regulatory background and authorities expectations on a suitable pest control programme in the field of GMP manufacturing. Additionally experts from manufacturing, laboratory and pest control companies present their experiences in developing and implementing a suitable pest control strategy. The presentations will cover the requirements for different areas and cleanroom classes and laboratories. Amongst the classic traps for rodents and insects, the course provides you information about modern online controlled pest control systems.

Background

Many national and international regulatory guidelines ask for a conclusive concept of pest control for pharmaceutical and biopharmaceutical manufacturers. But details what and how to do that can’t be found in these documents. It seems that this effects that the complexity and importance is underestimated. Mostly the small organisms of microbiology get more attention than the “big animals” that can be seen with the human eyes.
For an integrated and effective system to avoid pest infestation, a risked based approach for buildings, rooms and manufacturing conditions must be evaluated. Additionally the monitoring of the preventive actions, the traps and the corrective actions in case of pest infestation must be conceived.
Therefore, the exchange of information and a structured cooperation of the responsible persons of the manufacturer and maybe of the contact pest control supplier is essential.

Target Audience

This session is targeted for staff from

  • Manfacturing, construction and maintenance
  • Storage and Logistics
  • Procurement and Purchase
  • Outsourcing
  • Qualitiy
  • Contract Pest Control Companies

Congress Keynote

Congress Keynote 20.11.2018: Alternative Microbiological Methods: AstraZeneca's, Johnson&Johnson's, MSD's and Roche's Global Implementation Roadmap

Alternative Microbiological Methods: AstraZeneca's, Johnson&Johnson's, MSD's and Roche's Global Implementation Roadmap
Miriam Guest, Astra Zeneca / Philip Breugelmann, JnJ
Marja Claasen, MSD / Dr Sven M. Deutschmann, Roche

  • Introduction & Overview
  • Alternative Microbial Enumeration Method(s)
  • Alternative Sterility Test(s)
  • Alternative ID-Test(s)

Programme

Regulatory Expectations
Dr Rainer Gnibl, Government of Upper Bavaria

Pest Elimination – Outside to inside
Petra Barth, formerly AbbVie

  • Implementation of a system – the core of consideration
  • Zoning Concept against Bugs
  • Risked Based Approach – postions, Frequence and Limits
  • Acceptable Limits – an Approach of Evaluation
  • „Monitoring with a Logbook Concept - Chain of Reporting and Actions
  • Life Cycle of a Pest Control System

Possibilities and Limits of Monitoring Systems
Gerhard Karg, B.U.G.S

  • Monitoring for Rodent Control
  • Monitoring of different Insects
  • Possibilities of visual Control
  • Evaluation and interpretation of the Monitoring Data
  • How to start such systems

The Pest Management Standard in Pharma - Non-Toxic, zero tolerance and IoT Solutions
Tini Grauwet, SGS

  • Challenges of pest Management without biocides
  • The strength of direct and interactive web-based reporting
  • Permanent remote monitoring
  • IoT and other non-tox solutions
  • Success by partnership

GxP compliant Pest Control in Pharmaceutical Laboratories
Martin Tabak, Xendo b.v.

  • Relating GxP Rules
  • Survey about Pest Control Challenges in Pharmaceutical Laboratories
  • Results and Outcome
  • Take Home Message

Case Study: Pest Control Strategy for a New Laboratory Building
Dr Jürgen Balles, Labor LS

  • Overview about potential Pests in Lab and Laboratory Animal Husbandry
  • Possibilities of Identification and Monitoring
  • Riskevaluation relating to Preventive and Corrective Actions
  • Implementation in a new Lab Building

Pest Control Strategies for Phytopharmaceutical Manufacturing
Dr Cornelia Bodinet, Schaper & Brümmer

  • Fundamental Requirements and Measurements
  • "High Risk Area" Herbal Drugs Storage
  • Pest Control in the context of GACP
  • Case Studies
  • Inspection Experiences

Speakers

Dr Jürgen Balles, Labor LS, Germany
Managing Director.

Dr Cornelia Bodinet,Schaper & Brümmer, Germany
Head of Division“ Pharmaceutical Laboratories”.

Petra Barth, Former Abbvie
QA Trainer.

Dr Rainer Gnibl, Local Government of Upper Bavaria
GMP Inspector.

Tini Grauwet , SGS, Belgium
Business Unit Manager Pest Management Benelux.

Gerhard Karg, B.U.G.S, Germany
Managing Director.

Martin Tabak, Xendo, The Netherlands
Consultant